Switzerland (CH)

Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus (2021) Ma C, Schoepfer AM, Safroneeva E, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, et al. Journal article A Summary of the Meetings of the Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) International Multidisciplinary Consensus (2021) Ma C, Schoepfer AM, Safroneeva E, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, et al. Journal article Tunable cooperativity in coupled spin-cavity systems (2021) Liensberger L, Haslbeck FX, Bauer A, Berger H, Gross R, Huebl H, Pfleiderer C, Weiler M Journal article Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie – Update 2021 (2021) Ewig S, Kolditz M, Pletz MW, Altiner A, Albrich W, Droemann D, Flick H, et al. Journal article Adding Fairness to Order: Preventing Front-Running Attacks in BFT Protocols using TEEs (2021) Stathakopoulou C, Schwarz-Rüsch S, Brandenburger M, Vukolić M Conference contribution NOVEL MUTATIONS AND FINDINGS IN A COHORT OF MCLEOD NEUROACANTHOCYTOSIS, AN X-LINKED HD PHENOCOPY (2021) Peikert K, Schlotter-Weigel B, Montagnese F, Reilich P, Saft C, Marxreiter F, Kohl Z, et al. Conference contribution A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone compared to dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP) (2021) Binder M, Meyer O, Rummel M, Nimmerjahn F, Tesanovic T, Sauer T, Matzdorff A Conference contribution Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis (2021) Böttcher M, Bruns H, Lu J, Chartomatsidou E, Papakonstantinou N, Mentz K, Büttner-Herold M, et al. Conference contribution Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry (2021) Kuemmerle-Deschner J, Henes J, Kortus-Goetze B, Kallinich T, Oommen PT, Rech J, Weller-Heinemann F, et al. Conference contribution Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients (2021) Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, et al. Conference contribution